Syndax Pharmaceuticals (SNDX) Other Working Capital Changes (2017 - 2021)
Syndax Pharmaceuticals (SNDX) posted quarterly Other Working Capital Changes of -$12.4 million for Q3 2021, down 3156.58% year-over-year from $404864.4 in Q3 2020, and down 3165.17% quarter-over-quarter from -$379000.0 in Q2 2021.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Other Working Capital Changes (2017 - 2021) Analysis & Trends
Syndax Pharmaceuticals' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$12.4 million for Q3 2021.
- In Q3 2021, Other Working Capital Changes fell 3156.58% year-over-year to -$12.4 million; the TTM figure through Dec 2022 stood at -$12.8 million (up 2.89% YoY), while the FY2021 annual figure was -$13.1 million, down 765.72% from the prior year.
- Other Working Capital Changes for Q3 2021 stood at -$12.4 million, down from -$379000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $14.5 million in Q4 2025, with the low at -$7.8 million in Q1 2026.
- The 5-year median for Other Working Capital Changes is -$1.4 million (2024), against an average of $416133.3.
- The sharpest annual moves came in 2019 and 2021: Other Working Capital Changes changed 0.0% in 2019, then plunged 3156.58% in 2021.
- Syndax Pharmaceuticals' Other Working Capital Changes stood at $3.8 million in 2017, then plunged by 109.96% to -$379000.0 in 2018, then changed by 0.0% to -$379000.0 in 2019, then changed by 0.0% to -$379000.0 in 2020, then slumped by 3165.17% to -$12.4 million in 2021.
- Business Quant data shows SNDX's Other Working Capital Changes at -$12.4 million in Q3 2021, -$379000.0 in Q2 2021, and -$379000.0 in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Syndax Pharmaceuticals | 1.83 Bn | 1.28 Bn | 60.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | -12.38 Mn |
| Sep 30, 2021 | -12.38 Mn |
| Jun 30, 2021 | -379,000.00 |
| Jun 30, 2021 | -379,000.00 |
| Mar 31, 2021 | -379,000.00 |
| Mar 31, 2021 | -379,000.00 |
| Dec 31, 2020 | -379,000.00 |
| Dec 31, 2020 | -379,000.00 |
| Sep 30, 2020 | -380,000.00 |
| Sep 30, 2020 | -380,000.00 |
| Jun 30, 2020 | -379,000.00 |
| Jun 30, 2020 | -379,000.00 |
| Mar 31, 2020 | -379,000.00 |
| Mar 31, 2020 | -379,000.00 |
| Dec 31, 2019 | -379,000.00 |
| Dec 31, 2019 | -379,000.00 |
| Sep 30, 2019 | -380,000.00 |
| Sep 30, 2019 | -380,000.00 |
| Jun 30, 2019 | -379,000.00 |
| Jun 30, 2019 | -379,000.00 |